Currency in USD
Earnings estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
No. of analysts | 5 | 5 | 4 | 5 |
Avg. Estimate | 3.45 | 3.85 | 14.4 | 15.12 |
Low estimate | 3.34 | 3.25 | 14.27 | 14.95 |
High estimate | 3.62 | 4.41 | 14.55 | 15.3 |
Year ago EPS | 3.21 | 4.94 | 15.66 | 14.4 |
Revenue estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
No. of analysts | 4 | 4 | 5 | 5 |
Avg. Estimate | 742.25M | 684.54M | 2.82B | 2.91B |
Low estimate | 731.6M | 661.87M | 2.8B | 2.8B |
High estimate | 752.1M | 718.7M | 2.83B | 3.01B |
Year ago sales | 732.77M | 700.06M | 2.92B | 2.82B |
Sales growth (year/est) | 1.30% | -2.20% | -3.60% | 3.50% |
Earnings history | 30/12/2021 | 30/03/2022 | 29/06/2022 | 29/09/2022 |
---|
Est. EPS | 2.85 | 3.4 | 2.8 | 2.78 |
Actual EPS | 3.21 | 4.94 | 3.38 | 2.6 |
Difference | 0.36 | 1.54 | 0.58 | -0.18 |
Surprise % | 12.60% | 45.30% | 20.70% | -6.50% |
EPS trend | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
Current estimate | 3.45 | 3.85 | 14.4 | 15.12 |
7 days ago | 3.45 | 3.85 | 14.4 | 15.12 |
30 days ago | 3.47 | 3.92 | 14.43 | 15.22 |
60 days ago | 3.47 | 3.92 | 14.43 | 15.22 |
90 days ago | 3.47 | 3.8 | 14.45 | 15.09 |
EPS revisions | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 1 | 1 | 1 | 1 |
Growth estimates | BIO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 7.50% | N/A | N/A | N/A |
Next qtr. | -22.10% | N/A | N/A | N/A |
Current year | -8.00% | N/A | N/A | N/A |
Next year | 5.00% | N/A | N/A | N/A |
Next 5 years (per annum) | 17.80% | N/A | N/A | N/A |
Past 5 years (per annum) | 49.85% | N/A | N/A | N/A |